Is there Vaccine for COVID19?

1. Yes
2. There are now several vaccines that are in clinical use. The first mass production of vaccination programme started in early December 2020 and running successfully.

What are the current Vaccines available for COVID19?

1. Several different types of vaccines for COVID-19 have been developed and are currently in use including:
1. Latest updates on COVID19 vaccines: Click Here

What are the currently available vaccines in my Country?

1. There are various vaccination programs running across the world and ech country has separate arrangements.
2. See the current approved vaccines in your country: Click Here

Will COVID-19 vaccines provide long-term protection?

1. As the COVID vaccines have recently been developed, so we have limited research available for the long term.
2. The currently evidence is suggesting of 6 months, but this may change as there is ongoing follow-up of patients who have been vaccinated.
3. The current evidence is very encouraging about the prevention of severe disease in people who were vaccinated and had re-infection. Those who were vaccinated had only mild infection symptoms.

Currently there have been extensive research undertaken since the start of pandemic for the development of Vaccines for COVID19 infection. Several different types of vaccines for COVID-19 are developed using various methods, including:

1. RNA and DNA Vaccines: a new cutting-edge technology/approach that uses genetically engineered RNA or DNA to generate a protein that itself safely prompts an immune response (BioNTech/Pfizer and Moderna vaccines)
2. Inactivated or weakened virus vaccines, which use a form of the virus that has been inactivated or weakened so it doesn’t cause disease, but still generates an immune response. (Sinovac)
3. Protein-based vaccines, which use harmless fragments of proteins or protein shells that mimic the COVID-19 virus to safely generate an immune response. (Novavax)
4. Viral vector vaccines, which use a safe virus that cannot cause disease but serves as a platform to produce coronavirus proteins to generate an immune response. (University of Oxford/AstraZeneca)

1. Currently there is NO treatment available against the COVID19 infection.
2. The current treatments used in community or hospitals are only supportive and not definitive.
3. The COVID-19 vaccines produce protection against the disease, as a result of developing an immune response to the SARS-Cov-2 virus. Developing immunity through vaccination means there is a reduced risk of developing the illness and its complications
4. If you are vaccinated, your body develops antibodies (defensive chemicals). This immunity helps you fight the virus if exposed
5. Similarly, getting vaccinated may also protect people around you, because if you are protected from getting infected and from disease, you are less likely to infect someone else. This is particularly important to protect people at increased risk for severe illness from COVID-19, such as healthcare providers, older or elderly adults, and people with other medical conditions.

1. The COVID-19 vaccines are safe for most people 16 years and older, including those with pre-existing conditions of any kind, including auto-immune disorders.
2. These conditions include: hypertension, diabetes, asthma, pulmonary, liver and kidney disease, as well as chronic infections that are stable and controlled.
3. There is no COVID-19 vaccine yet for children under age 16 but the clinical studies are currently ongoing children as young as age 12.
4. You must discuss with your physician if:
1. Have a history of severe allergies, particularly to a vaccine (or any of the ingredients in the vaccine)
2. Are severely frail

1. Remember Vaccination DOEST NOT protect you 100 %.
2. Vaccination protects you from getting seriously ill and dying from COVID-19.
3. For the first 14- days after getting a vaccination, you do not have significant levels of protection, then it increases gradually.
4. For a single dose vaccine, immunity will generally occur two weeks after vaccination. For two-dose vaccines, both doses are needed to achieve are required to provide the highest level of best immunity possible.
5. Currently there is ongoing research to assess
1. The extent to which it keeps you from being infected
2. Passing the virus on to others
6. To help keep others safe, continue to maintain at least a 1-metre distance from others, cover a cough or sneeze in your elbow, clean your hands frequently and wear a mask, particularly in enclosed, crowded or poorly ventilated spaces.
7. Always follow guidance from local authorities based on the situation and risk where you live.

1. Currently is advisable to continue with the same vaccine for the second dose
2. There are currently Clinical trials in progress to looking at whether you can have a first dose from one vaccine and a second dose from a different vaccine. There isn't enough data yet to recommend this type of combination.

1. No
2. The COVID-19 vaccine will not cause a positive test result for a COVID-19 PCR or antigen laboratory test. This is because the tests check for active disease and not whether an individual is immune or not. However, because the COVID-19 vaccine prompts an immune response, it may be possible to test positive in an antibody (serology) test that measures COVID-19 immunity in an individual.

1. Even if you have already had COVID-19, The protection that someone gains from having COVID-19 will vary from person to person, and we also don’t know how long natural immunity might last.
2. As there is a risk of reinfection is possible, therefore you should be vaccinated.
3. If you’ve had COVID-19, you might delay vaccination until 90 days after your diagnosis.

1. There is no COVID-19 vaccine yet for children under age 16 but the clinical studies are currently ongoing children as young as age 12.
2. In the meantime, make sure children continue to physical distance from others, clean their hands frequently, sneeze and cough into their elbow and wear a mask if age appropriate.

1. The current 3 variants of the virus that causes COVID-19 includes:
1. The United Kingdom (UK) identified called B.1.1.7
2. South Africa variant called B.1.351
3. Brazil, variant called P.1
2. These variants seem to spread more easily and quickly than other variants.
3. Antibodies generated through vaccination with currently authorized vaccines recognize these variants.
4. The response Even if the current vaccines are less effective against some variants, they still provide some level of protection from becoming sick with COVID-19. Additionally, when more people have some immunity, the transmission of the virus can be slowed.

1. Ensuring the safety and quality of vaccines is one of world-health- organization top priorities.
2. COVID-19 vaccines development goes through a rigorous, multi-stage testing process, including large (phase III) trials that involve tens of thousands of people.
3. These trials are fully monitored and data is assessed by independent investigators to assess for the COVID-19 vaccine safety and effectiveness.
4. After a COVID-19 vaccine is introduced, WHO and other regulatory authorities work with vaccine manufacturers, health officials in each country, and other partners to monitor for any safety concerns on an ongoing basis.

1. COVID19- Infection Tracker: Click Here
2. COVID19-Vaccines administered Tracker: Click Here
3. COVID19-Vaccines in Use/development Tracker: Click Here
4. COVID19 Vaccines approved/available in my country: Click Here